SSPE
Introduction And Epidemiology
- Subacute Sclerosing Panencephalitis (SSPE) constitutes a rare, chronic, progressive, and almost invariably fatal neurodegenerative disorder of the central nervous system.
- The disease is caused by a persistent infection with a defective variant of the wild-type measles virus and is classified as a slow virus infection due to its long latency period.
- While largely eliminated in developed nations through vaccination, it remains highly prevalent in developing countries like India, with incidences reaching up to 21 cases per 100,000 population in southern regions.
- Primary measles infection occurring before 2 years of age accounts for 50% of cases, and before 4 years accounts for 75% of cases, representing the most critical risk factor.
- A distinct male preponderance exists, affecting boys two to three times more frequently than girls, with a higher incidence frequently observed in rural populations.
Etiology And Pathophysiology
- SSPE is strictly caused by a defective wild-type measles virus; the live attenuated vaccine virus does not cause the disease.
- The primary viral defect involves the Matrix (M) protein, which is rendered absent or non-functional due to biased hypermutations characterized by U-to-C transitions.
- This defect prevents the virus from assembling complete virions and budding out of the cell.
- The virus persists by spreading directly from cell to cell via fusion utilizing ribonucleoprotein complexes, effectively evading circulating neutralizing antibodies.
- Following a latency period averaging 7 to 10 years, a massive but ineffective humoral inflammatory response triggers extensive demyelination, gliosis, and neuronal death.
Pathological Findings
- Macroscopic Findings:
- The brain develops marked cortical atrophy, predominantly affecting the occipital and parietal lobes, alongside distinct ventriculomegaly and a firm consistency driven by gliosis.
- Microscopic Findings:
- The classic hallmark is panencephalitis involving both grey and white matter.
- Essential features include perivascular cuffing, extensive white matter demyelination, and pathognomonic eosinophilic intranuclear and intracytoplasmic inclusion bodies termed Cowdry type A.
Clinical Manifestations #staging
The clinical course typically affects children between 5 and 15 years of age and progresses through four classic Jabbour stages.
| Clinical Stage | Duration | Cardinal Clinical Features |
|---|---|---|
| Stage I (Psychointellectual) | Weeks to months | Insidious decline in school performance, forgetfulness, distractibility, lethargy, and behavioral changes like temper tantrums; overt neurological signs are absent. |
| Stage II (Myoclonic) | 3 to 12 months | Characterized by massive, repetitive, synchronous myoclonic jerks occurring every 5 to 10 seconds, which disappear during sleep; accompanied by clumsiness, ataxia, and dysarthria. |
| Stage III (Extrapyramidal) | Variable | Myoclonus disappears and is replaced by lead-pipe rigidity, decorticate or decerebrate posturing, dystonia, progressive dementia, stupor, dysphagia, and profound autonomic instability. |
| Stage IV (Vegetative) | Terminal | The patient enters an akinetic mutism or vegetative state; death typically results from intercurrent infections, bulbar palsy, or complete autonomic failure. |
- Ocular manifestations, specifically chorioretinitis with macular pigmentary changes, occur in 10% to 50% of patients and may precede neurological symptoms.
Diagnostic Evaluation
Diagnosis is established using Dykenβs Criteria, which require the presence of three out of five specific parameters: typical clinical presentation, characteristic EEG changes, elevated cerebrospinal fluid (CSF) globulin, elevated serum and CSF measles antibody titers, and a consistent brain biopsy.
| Diagnostic Modality | Characteristic Findings |
|---|---|
| Electroencephalogram (EEG) | Pathognomonic Radermecker complexes appear as periodic, synchronous, high-voltage polyphasic slow-wave bursts occurring every 4 to 10 seconds, demonstrating a 1:1 relationship with myoclonic jerks against a burst-suppression background. |
| Cerebrospinal Fluid (CSF) | Features a normal cell count and glucose level but distinctly reveals markedly elevated anti-measles IgG titers. Oligoclonal IgG bands specific to measles antigens are present, and a Serum:CSF measles antibody ratio below 40:1 confirms intrathecal antibody synthesis. |
| Neuroimaging (MRI) | Early stages demonstrate high signal intensity on T2/FLAIR images in the periventricular white matter and subcortical regions; late stages reveal generalized cortical and subcortical atrophy. |
Management And Prognosis
- No curative therapy exists for SSPE; the disease is relentlessly progressive, with death typically occurring within 1 to 3 years of diagnosis.
- Specific Pharmacotherapy: Oral Inosiplex (Isoprinosine) administered at 100 mg/kg/day may prolong survival and stabilize the disease in 30% to 50% of patients if initiated early in Stage I. This is frequently combined with Interferon-alpha administered via the intrathecal or intraventricular route.
- Symptomatic Therapy: Anticonvulsants such as Carbamazepine or Valproate are highly effective in controlling distressing myoclonic jerks, though they do not alter disease progression.
- Prevention: Universal measles vaccination represents the only effective preventive measure. Catch-up campaigns ensuring high coverage (>95%) are critical to protect vulnerable infants.